Search
for
Sort by
Research 29
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Atypical clinical presentation of primary and secondary cutaneous follicle center lymphoma (FCL) on the head characterized by macular lesions
- Severe steroid-dependent idiopathic angioedema with response to rituximab
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- SAT-214 Satoyoshi Syndrome: A Rare Cause of Premature Ovarian Failure
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- A rare case of TEN-like acute cutaneous lupus
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Rare presentation of disseminated follicular lymphoma as an ill-defined reticular patch over the scalp and forehead
- VII International Congress, Asociación Dermatológica del Caribe (Dermocaribe), Cartagena de Indias, Colombia, March 17-20, 2011
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Non-scarring Alopecia in Pemphigus Foliaceus
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 2 approved]
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved]
- EP06 Successful treatment of alopecia universalis with rituximab therapy
- Adverse Effects and Drug Interactions of Biologic Agents
- Ethical Principles for Everyone
- Lupus erythematosus: systemic and cutaneous manifestations
- The spectrum of nephrocutaneous diseases and associations
- Rituximab for Bone Lymphoma
- The Efficacy of Spiritual Healing
- Blinding in Placebo-Controlled Trials
- Medications
- Blinding in Placebo-Controlled Trials
- Index
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine